Falsely Elevated 25-Hydroxy-Vitamin D Levels in Patients with Hypercalcemia
Joint Authors
Choi, Moon Kyung
Putthapiban, Prapaipan
Lekprasert, Patamaporn
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-08-09
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Symptomatic hypercalcemia is a commonly encountered clinical scenario.
Though it is important to collect detailed history to find clinical clues connecting to the etiology of hypercalcemia, the diagnostic workup of hypercalcemia depends heavily on laboratory analysis.
Accurate measurement of the parathyroid hormone and vitamin D levels is essential.
However, commercial laboratory measurement of vitamin D levels can be erroneous in the setting of abundant paraprotein in the serum.
One of the most common conditions that can cause an increased amount of paraproteins is multiple myeloma.
We report 2 cases of falsely elevated 25-hydroxy-vitamin D levels in patients presenting with hypercalcemia and an underlying diagnosis of MM.
American Psychological Association (APA)
Choi, Moon Kyung& Putthapiban, Prapaipan& Lekprasert, Patamaporn. 2020. Falsely Elevated 25-Hydroxy-Vitamin D Levels in Patients with Hypercalcemia. Case Reports in Endocrinology،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1147134
Modern Language Association (MLA)
Choi, Moon Kyung…[et al.]. Falsely Elevated 25-Hydroxy-Vitamin D Levels in Patients with Hypercalcemia. Case Reports in Endocrinology No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1147134
American Medical Association (AMA)
Choi, Moon Kyung& Putthapiban, Prapaipan& Lekprasert, Patamaporn. Falsely Elevated 25-Hydroxy-Vitamin D Levels in Patients with Hypercalcemia. Case Reports in Endocrinology. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1147134
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1147134